These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 1707692

  • 1. Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells.
    Fazely F, Dezube BJ, Allen-Ryan J, Pardee AB, Ruprecht RM.
    Blood; 1991 Apr 15; 77(8):1653-6. PubMed ID: 1707692
    [Abstract] [Full Text] [Related]

  • 2. Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. NIAID AIDS Clinical Trials Group.
    Dezube BJ, Pardee AB, Chapman B, Beckett LA, Korvick JA, Novick WJ, Chiurco J, Kasdan P, Ahlers CM, Ecto LT.
    J Acquir Immune Defic Syndr (1988); 1993 Jul 15; 6(7):787-94. PubMed ID: 8099612
    [Abstract] [Full Text] [Related]

  • 3. Pentoxifylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumour necrosis factor synthesis or nuclear factor-kappa B activation.
    Navarro J, Punzón MC, Pizarro A, Fernández-Cruz E, Fresno M, Muñoz-Fernández MA.
    AIDS; 1996 May 15; 10(5):469-75. PubMed ID: 8724037
    [Abstract] [Full Text] [Related]

  • 4. Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication.
    Angel JB, Saget BM, Walsh SP, Greten TF, Dinarello CA, Skolnik PR, Endres S.
    AIDS; 1995 Oct 15; 9(10):1137-44. PubMed ID: 8519449
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
    Mhashilkar AM, Biswas DK, LaVecchio J, Pardee AB, Marasco WA.
    J Virol; 1997 Sep 15; 71(9):6486-94. PubMed ID: 9261367
    [Abstract] [Full Text] [Related]

  • 6. Thalidomide inhibits the replication of human immunodeficiency virus type 1.
    Makonkawkeyoon S, Limson-Pobre RN, Moreira AL, Schauf V, Kaplan G.
    Proc Natl Acad Sci U S A; 1993 Jul 01; 90(13):5974-8. PubMed ID: 8327469
    [Abstract] [Full Text] [Related]

  • 7. In vitro evidence for a dual role of tumor necrosis factor-alpha in human immunodeficiency virus type 1 encephalopathy.
    Wilt SG, Milward E, Zhou JM, Nagasato K, Patton H, Rusten R, Griffin DE, O'Connor M, Dubois-Dalcq M.
    Ann Neurol; 1995 Mar 01; 37(3):381-94. PubMed ID: 7695238
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor.
    Herbein G, Montaner LJ, Gordon S.
    J Virol; 1996 Nov 01; 70(11):7388-97. PubMed ID: 8892857
    [Abstract] [Full Text] [Related]

  • 9. Pentoxifylline for the treatment of HIV infection and its complications.
    Dezube BJ, Lederman MM.
    J Cardiovasc Pharmacol; 1995 Nov 01; 25 Suppl 2():S139-42. PubMed ID: 8699854
    [Abstract] [Full Text] [Related]

  • 10. Valproic acid reduces the intracellular level of glutathione and stimulates human immunodeficiency virus.
    Simon G, Moog C, Obert G.
    Chem Biol Interact; 1994 Jun 01; 91(2-3):111-21. PubMed ID: 7514959
    [Abstract] [Full Text] [Related]

  • 11. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P, Kwon H, Clarke M, Lin R, Sonenberg N, Wainberg M, Hiscott J.
    J Virol; 1996 Sep 01; 70(9):5777-85. PubMed ID: 8709193
    [Abstract] [Full Text] [Related]

  • 12. Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-kappa B action.
    Biswas DK, Dezube BJ, Ahlers CM, Pardee AB.
    J Acquir Immune Defic Syndr (1988); 1993 Jul 01; 6(7):778-86. PubMed ID: 8509980
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells.
    Rabbi MF, Finnegan A, Al-Harthi L, Song S, Roebuck KA.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec 01; 19(4):321-31. PubMed ID: 9833740
    [Abstract] [Full Text] [Related]

  • 14. Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism.
    Peterson PK, Gekker G, Chao CC, Hu SX, Edelman C, Balfour HH, Verhoef J.
    J Clin Invest; 1992 Feb 01; 89(2):574-80. PubMed ID: 1310698
    [Abstract] [Full Text] [Related]

  • 15. Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kappa B activation.
    Muñoz-Fernández MA, Navarro J, Garcia A, Punzón C, Fernández-Cruz E, Fresno M.
    J Allergy Clin Immunol; 1997 Dec 01; 100(6 Pt 1):838-45. PubMed ID: 9438495
    [Abstract] [Full Text] [Related]

  • 16. Cell-specific differences in activation of NF-kappa B regulatory elements of human immunodeficiency virus and beta interferon promoters by tumor necrosis factor.
    Lacoste J, D'Addario M, Roulston A, Wainberg MA, Hiscott J.
    J Virol; 1990 Oct 01; 64(10):4726-34. PubMed ID: 2204723
    [Abstract] [Full Text] [Related]

  • 17. Pentoxifylline and other protein kinase C inhibitors down-regulate HIV-LTR NF-kappa B induced gene expression.
    Biswas DK, Ahlers CM, Dezube BJ, Pardee AB.
    Mol Med; 1994 Nov 01; 1(1):31-43. PubMed ID: 8790599
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of HIV-1 replication by combination of a novel inhibitor of TNF-alpha with AZT.
    Biswas DK, Mhashilkar AM, Ewaniuk DS, Pezza JA, Oh LM, Kannangara GS, Tius MA, Pardee AB.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug 15; 18(5):426-34. PubMed ID: 9715838
    [Abstract] [Full Text] [Related]

  • 19. CD8+ T cell-mediated enhancement of tumour necrosis factor-alpha (TNF-alpha) production and HIV-1 LTR-driven gene expression in human monocytic cells is pertussis toxin-sensitive.
    Copeland KF, McKay PJ, Newton J, Rosenthal KL.
    Clin Exp Immunol; 1999 Jun 15; 116(3):479-85. PubMed ID: 10361238
    [Abstract] [Full Text] [Related]

  • 20. CT-2576, an inhibitor of phospholipid signaling, suppresses constitutive and induced expression of human immunodeficiency virus.
    Leung DW, Peterson PK, Weeks R, Gekker G, Chao CC, Kaplan AH, Balantac N, Tompkins C, Underiner GE, Bursten S.
    Proc Natl Acad Sci U S A; 1995 May 23; 92(11):4813-7. PubMed ID: 7761405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.